Osaic Holdings
ELDN icon

Osaic Holdings’s Eledon Pharmaceuticals ELDN Stock Holding History

Osaic Holdings’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.3K Buy
7,276
+246
+3% +$827 ﹤0.01% 6254
2026
Q2 		$27.7K Buy
7,030
+6,625
+1,636% +$24.1K ﹤0.01% 5911
2026
Q1 		$1.25K Hold
405
– – ﹤0.01% 7195
2025
Q4 		$611 Sell
405
-9,595
-96% -$22.8K ﹤0.01% 7401
2025
Q3 		$25.9K Buy
+10,000
New +$29.2K ﹤0.01% 5761

Other funds holding ELDN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
AIC
AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return
22NW LP
22NW LP Seattle, Washington $144M AUM 2.58% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Osaic Holdings's ELDN Position: Q3 2026 in Review

Osaic Holdings increased its Eledon Pharmaceuticals (ELDN) stake by 3.5% in Q3 2026, buying an estimated $827 and bringing the position to 7,276 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6254.

Osaic Holdings first reported a position in ELDN in Q3 2025 and has held it in 5 quarters since. The position peaked at $27.7K in Q2 2026. 114 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Osaic Holdings held 7,276 shares of Eledon Pharmaceuticals worth $18.3K as of Q3 2026.
  • Osaic Holdings bought 246 Eledon Pharmaceuticals shares in Q3 2026, an estimated $827.
  • Eledon Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6254 holding.
  • Osaic Holdings first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Osaic Holdings's Eledon Pharmaceuticals position peaked at $27.7K in Q2 2026.
  • 114 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.